Viewing Study NCT00000633

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-01-22 @ 3:53 PM
Study NCT ID: NCT00000633
Status: COMPLETED
Last Update Posted: 2021-11-02
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaccines, Synthetic View
None Vaccinia Virus View
None Viral Vaccines View
None HIV-1 View
None HIV Envelope Protein gp160 View
None Acquired Immunodeficiency Syndrome View
None AIDS-Related Complex View
None AIDS Vaccines View
None HIV Therapeutic Vaccine View